狄诺塞麦停药后发生的临床椎体骨折。 - Suppr

Suppr

超能文献

Clinical vertebral fractures following denosumab discontinuation.

作者信息

Polyzos Stergios A, Terpos Evangelos

机构信息

School of Medicine, University of Athens, Athens, Greece.

出版信息

Endocrine. 2016 Oct;54(1):271-272. doi: 10.1007/s12020-016-1030-6. Epub 2016 Jul 8.

DOI:10.1007/s12020-016-1030-6

PMID:27393301

Abstract

摘要

相似文献

Clinical vertebral fractures following denosumab discontinuation.狄诺塞麦停药后发生的临床椎体骨折。

Endocrine. 2016 Oct;54(1):271-272. doi: 10.1007/s12020-016-1030-6. Epub 2016 Jul 8.

Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.地诺单抗停药后发生严重自发性椎体骨折：三例病例报告

Osteoporos Int. 2016 May;27(5):1923-5. doi: 10.1007/s00198-015-3380-y. Epub 2015 Oct 28.

Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics.地诺单抗停用后与反弹相关的椎体骨折——来自临床和生物力学研究

Osteoporos Int. 2016 May;27(5):1917-21. doi: 10.1007/s00198-015-3458-6. Epub 2015 Dec 22.

Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: 9 Clinical Cases Report.地诺单抗停药后严重的反弹相关椎体骨折：9例临床病例报告

J Clin Endocrinol Metab. 2017 Feb 1;102(2):354-358. doi: 10.1210/jc.2016-3170.

Denosumab: a novel antiresorptive drug for osteoporosis.地诺单抗：一种用于治疗骨质疏松症的新型抗吸收药物。

Cleve Clin J Med. 2015 Feb;82(2):105-14. doi: 10.3949/ccjm.82a.13173.

Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT).绝经后日本骨质疏松症女性和男性接受三年地诺单抗治疗：地诺单抗骨折干预随机安慰剂对照试验（DIRECT）1年开放标签扩展研究的结果

Osteoporos Int. 2015 Feb;26(2):765-74. doi: 10.1007/s00198-014-2964-2. Epub 2014 Nov 18.

Rebound vertebral and non-vertebral fractures during denosumab interruption in a postmenopausal woman.一名绝经后女性在狄诺塞麦中断治疗期间出现椎体和非椎体骨折反弹。

Clin Endocrinol (Oxf). 2019 Jan;90(1):250-252. doi: 10.1111/cen.13867. Epub 2018 Oct 30.

Rebound-associated vertebral fractures after discontinuation of denosumab for the treatment of maxillitis.地舒单抗治疗颌骨炎停药后与反跳相关的椎体骨折。

Osteoporos Int. 2018 Mar;29(3):769-772. doi: 10.1007/s00198-017-4334-3. Epub 2017 Dec 11.

Spontaneous vertebral fractures after denosumab discontinuation: A case collection and review of the literature.地舒单抗停药后自发性椎体骨折：病例收集和文献复习。

Semin Arthritis Rheum. 2019 Oct;49(2):197-203. doi: 10.1016/j.semarthrit.2019.02.007. Epub 2019 Feb 15.

Remarkable loss of bone mineral density in 6 months after denosumab discontinuation: a case report.地舒单抗停药后 6 个月内显著的骨密度损失：一例报告。

Mod Rheumatol Case Rep. 2020 Jul;4(2):218-221. doi: 10.1080/24725625.2019.1702494. Epub 2020 Jan 6.

引用本文的文献

J Clin Med. 2023 Sep 10;12(18):5874. doi: 10.3390/jcm12185874.

Trabecular bone deterioration in a postmenopausal female suffering multiple spontaneous vertebral fractures due to a delayed denosumab injection - A post-treatment re-initiation bone biopsy-based case study.因地诺单抗注射延迟导致多发性自发性椎体骨折的绝经后女性小梁骨恶化——一项基于治疗后重新开始的骨活检的病例研究。

Bone Rep. 2023 Jul 22;19:101703. doi: 10.1016/j.bonr.2023.101703. eCollection 2023 Dec.

The Role of Bisphosphonates Prior to Denosumab Treatment on Rebound Fractures: A Mini Review.地诺单抗治疗前双膦酸盐对反跳性骨折的作用：一篇综述。

J Bone Metab. 2022 Nov;29(4):217-223. doi: 10.11005/jbm.2022.29.4.217. Epub 2022 Nov 30.

Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases.地舒单抗停药后骨折：797 例回顾性研究。

J Bone Miner Res. 2021 Sep;36(9):1717-1728. doi: 10.1002/jbmr.4335. Epub 2021 May 19.

Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review.地诺单抗停药与反弹现象：一篇叙述性综述

J Clin Med. 2021 Jan 4;10(1):152. doi: 10.3390/jcm10010152.

Treatment with zoledronic acid subsequent to odanacatib prevents bone loss in postmenopausal women with osteoporosis.唑来膦酸治疗可预防绝经后骨质疏松症妇女的骨丢失。

Osteoporos Int. 2019 May;30(5):995-1002. doi: 10.1007/s00198-018-04833-3. Epub 2019 Jan 17.

Advances and Unmet Needs in the Therapeutics of Bone Fragility.骨脆性治疗的进展与未满足需求

Front Endocrinol (Lausanne). 2018 Sep 6;9:505. doi: 10.3389/fendo.2018.00505. eCollection 2018.

Multiple vertebral fractures following osteoporosis treatment discontinuation: a case-report after long-term Odanacatib.骨质疏松症治疗停药后多发椎体骨折：长期使用odanacatib 后的 1 例报告

Osteoporos Int. 2018 Apr;29(4):999-1002. doi: 10.1007/s00198-018-4385-0. Epub 2018 Feb 18.

Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study.长期停用地舒单抗治疗后显著的骨丢失：FREEDOM 研究后。

Osteoporos Int. 2018 Jan;29(1):41-47. doi: 10.1007/s00198-017-4242-6. Epub 2017 Oct 3.

Denosumab: an Emerging Therapy in Pediatric Bone Disorders.地舒单抗：儿科骨骼疾病的新兴治疗方法。

Curr Osteoporos Rep. 2017 Aug;15(4):283-292. doi: 10.1007/s11914-017-0380-1.

本文引用的文献

Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics.地诺单抗停用后与反弹相关的椎体骨折——来自临床和生物力学研究

Osteoporos Int. 2016 May;27(5):1917-21. doi: 10.1007/s00198-015-3458-6. Epub 2015 Dec 22.

Multiple clinical vertebral fractures following denosumab discontinuation.地诺单抗停药后出现多发性临床椎体骨折。

Osteoporos Int. 2016 May;27(5):1929-30. doi: 10.1007/s00198-015-3459-5. Epub 2015 Dec 22.

Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.地诺单抗停药后发生严重自发性椎体骨折：三例病例报告

Osteoporos Int. 2016 May;27(5):1923-5. doi: 10.1007/s00198-015-3380-y. Epub 2015 Oct 28.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验